RE
RemeGen Co., Ltd.
REGMF · OTC
$10.93 +0.00% (+$0.00)
1M +14.57%
Market Cap ¥41.3B
P/E Ratio 7.14x
Div. Yield -
ROE 127.36%
Bulios Fair Price
$10.65
2.6% downside
Current Price
$10.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, REGMF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
83 /100
Cheap EV/EBITDA 7.97x
P/S 5.19x
P/B 4.96x
Growth
78 /100
Growing Book val. growth 10.17%
Rev. growth 60.38%
FCF growth N/A
Profitability
100 /100
Strong Net margin 72.71%
Op. margin 61.13%
FCF margin 54.67%
Quality
95 /100
Excellent ROE 127.36%
ROA 58.71%
Asset turnover 0.81x
Debt
100 /100
Low Current ratio 4.86x
Int. coverage 106.63x
Net debt/EBITDA -0.25x
Stability
34 /100
Moderate Rev. volatility 22.62%
EPS volatility 101.11%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about REGMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Min Fang
Employees
3,048
Headquarters
Yantai
Upcoming events
04 NOV
Earnings
Upcoming earnings report